
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy - 2
I’m a neuroscientist who taught rats to drive − their joy suggests how anticipating fun can enrich human life - 3
Israel scales back use of top missile interceptors as Iran barrages persist - 4
An ex-FBI agent analyzes what we learned from Savannah Guthrie's 'Today' show interview amid the search for her mother Nancy - 5
Mating injuries may lead scientists to identify dinosaurs’ sex
Surprising links between autism, Alzheimer’s could change how we treat both
Vote in favor of the subject that you see as generally captivating and intelligent!
The most effective method to Settle on Informed Conclusions about Senior Insuranc.
Terminal cancer diagnosis announced by JFK's granddaughter
Mississippi Insight for Jan. 11, 2026
Doctor's orders? ‘Belly laugh at least two to five days a week'
Rediscovering Euphoria: Individual Accounts of Conquering Despondency
Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025
Here's how 'Bridgerton' fans can watch the first episode of Season 4 before its Netflix release later this month












